Abstract: The present invention relates to three-branched PEG-G-CSF conjugate of general formula (1) in which the bonding ratio of three-branched polyethylene glycol (PEG) and G-CSF is 1:1 (mol/mol), wherein PEG has an average molecular weight of from 200 to 45,000 daltons; a pharmaceutical composition comprising the same, and a preparing method thereof.

Abstract: Provided are a fax data transmission controller, a fax server, a fax system. and a method of providing the fax system. The fax data transmission controller can store fax data received via a public switched telephone network (PSTN), and transmit the stored fax data to a fax server, to a facsimile, or to a user computer. The fax server can filter fax data that is received or to be transmitted, and perform authentication on the content of the fax data.

Abstract: A method and system for managing facsimile (fax) data in an integrated manner. The system includes an integrated fax server, and a fax terminal configured to transmit and receive fax data via a first communication network and to transmit both the transmitted and received fax data to the integrated fax server via a second communication network. The integrated fax server stores fax data received from the fax terminal in a database. The fax terminal includes a fax machine connector configured to receive fax data from a fax machine, a first communication network connector configured to transmit and receive fax data via a first communication network, and a server interface unit configured to transmit fax data to the integrated fax server. Accordingly, the integrated fax server manages transmitted and received fax documents with increased efficiency and security. Thus, the difficulty of managing fax documents due to spacial restriction is diminished.

Abstract: A facsimile controlling device for facsimile security can receive or block a fax transmitted from a registered fax number. In addition, the facsimile controlling device for facsimile security may allow a transmission document to undergo authentication before being transmitted to the outside or may block the transmission document from being transmitted to a registered number.

Abstract: The present invention relates to three-branched polyethylene glycol-interferon alpha conjugate of general formula (1) wherein polyethylene glycol has an average molecular weight of from 400 to 45,000 daltons, and a pharmaceutical composition comprising the same. The bioactive polyethylene glycol-interferon alpha conjugate of general formula (1) has antiviral and antitumoral activities, improved yield and purity by high reactivity in the reaction, and the effects to increase the half-life in blood remarkably, and to minimize the decreases in biological activity of interferon.

Abstract: A developing unit of an image forming apparatus includes a developer cartridge detachably mounted on the developing unit, a developing case in which a developing member and a first supply member are provided, a developer supply passage to supply a developer stored in the developer cartridge to the developing case, and a developer supplement unit mounted in a portion connecting the developing case and the developer supply passage, to agitate the developer supplied through the developer supply passage and to supply the agitated developer to the developing case.